New insulin pump aims to tame blood sugar swings
NCT ID NCT07579702
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new insulin pump system, Omnipod 6, to the current Omnipod 5 in 200 people with type 1 or type 2 diabetes who have poor blood sugar control. Participants will use both pumps for a set time to see which one helps keep blood sugar in a healthy range more effectively and reduces dangerous lows. The goal is to find out if the upgraded system offers real benefits for daily diabetes management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omnipod 6 insulin pump system
What this could lead to
If it works, this could mean better blood sugar control and fewer dangerous lows for people with diabetes using an insulin pump.
What could go wrong
This is an early comparison study with only 200 participants, so results may not apply to everyone. The new pump might not show a meaningful improvement over the current model.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Emory University
NOT_YET_RECRUITINGAtlanta, Georgia, 30308, United States
Contact
Contact
-
Health Partners
RECRUITINGMinneapolis, Minnesota, 55416, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Henry Ford Health Systems
RECRUITINGDetroit, Michigan, 48202, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Indiana University
NOT_YET_RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Joslin Diabetes Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Northwestern University
NOT_YET_RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sansum Diabetes Research Institute
RECRUITINGSanta Barbara, California, 93105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Colorado
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of South Florida
NOT_YET_RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Southern California
NOT_YET_RECRUITINGLos Angeles, California, 90022, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yale
NOT_YET_RECRUITINGNew Haven, Connecticut, 06511, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact